MCKESSON Aktie

 

Based on the average brokerage recommendation (ABR), McKesson (MCK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day....

TEMPE, Ariz. & SAN JOSE, Calif. & DALLAS--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Britt Vitalone, Executive Vice President and Chief Financial Officer (“CFO”), McKesson Corporation, to Align's Board of Directors along with its Audit Committee. “I am pleased to welcome Britt to Align's board of directors,” said Joe Hogan, president and CEO of Align Technology. “His deep expertise as a business and financial leader in the healthcare industry will be an incredible asset to Align as we continue to drive growth and innovation globally by delivering digital solutions across the Align™ Digital Platform to help more doctors increase practice efficiency and deliver the best possible Inv...

McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market....

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights. We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

read more...

McKesson (MCK) concluded the recent trading session at $730.80, signifying a +1.82% move from its prior day's close....

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKesson's leadership team followed by a Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an update on the company's strategic priorities, growth strategies, and business outlook. A live webcast of the event and replay, along with the company's slide presentation will be available on McKesson's Investor Relations website at investor.mckesson.com, where you can find a complete listing of upcoming events, including details and updates. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to...

Tyler, Brian Scott - Vorstand - Tag der Transaktion: 2025-06-06...

McKesson has significantly outpaced the broader healthcare sector over the past year, and analysts remain strongly bullish on the stock's prospects....

WASHINGTON (dpa-AFX) - McKesson Corporation (MCK) has acquired a 70 percent controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC - Core Ventures, a business and administ......

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials....

Strengthens Community-Based Oncology Care with Florida Cancer Specialists & Research Institute Core VenturesIRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development, improve patient outcomes, and expand access to quality cancer care in local communities. McKesson acquired an approximate 70% controlling interest in Core Ventures for about $2.49 billion. FCS physicians retained an approximate 30% interest. FCS, a practice with more than 250 physicians and 280 advanced practice providers, across nearly 100 locations in Florida, remains independently owned and became a member of McKesson's The US On...

Rodgers, Thomas L. - Vorstand - Tag der Transaktion: 2025-05-30...

Das Instrument MCK US58155Q1031 MCKESSON DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 30.05.2025 und ex Dividende/Zinsen am 02.06.2025 The instrument MCK US58155Q1031 MCKESSON DL-,01 EQUITY has its pre-dividend/interest day on 30.05.2025 and its ex-dividend/interest day on 02.06.2025...

Rodgers, Thomas L. - Vorstand - Tag der Transaktion: 2025-05-28...